RISK OF THROMBOEMBOLIC DISEASES IN MEN WITH PROSTATE CANCER: RESULTS FROM PCBASE SWEDEN

被引：1
|
作者：
Van Hemelrijck, M. J. J. [1 ]
Adolfsson, J. [2 ]
Garmo, H. [1 ]
Bill-Axelson, A. [3 ]
Bratt, O. [4 ]
Ingelsson, E. [3 ]
Lambe, M. [3 ]
Stattin, P. [5 ]
Holmberg, L. [1 ]
机构：
[1] Kings Coll London, Dept Canc Epidemiol, London WC2R 2LS, England
[2] Karolinska Inst, Ctr Oncol, Dept Clintec, Stockholm, Sweden
[3] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[4] Lund Univ, Dept Urol, Lund, Sweden
[5] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60139-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [1] Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
    Van Hemelrijck, Mieke
    Adolfsson, Jan
    Garmo, Hans
    Bill-Axelson, Anna
    Bratt, Ola
    Ingelsson, Erik
    Lambe, Mats
    Stattin, Par
    Holmberg, Lars
    LANCET ONCOLOGY, 2010, 11 (05): : 450 - 458
  • [2] Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden
    Van Hemelrijck, Mieke
    Garmo, Hans
    Holmberg, Lars
    Ingelsson, Erik
    Bratt, Ola
    Bill-Axelson, Anna
    Lambe, Mats
    Stattin, Par
    Adolfsson, Jan
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3448 - 3456
  • [3] RISK PATTERNS OF FRACTURES AND CARDIOVASCULAR AND THROMBOEMBOLIC DISEASE, FOLLOWING PROSTATE CANCER TREATMENT: RESULTS FROM THE POPULATION-BASED PCBASE SWEDEN
    Van Hemelrijck, M.
    Garmo, H.
    Holmberg, H.
    Lambe, M.
    Stattin, P.
    Adolfsson, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 252 - 253
  • [4] ABSOLUTE AND RELATIVE RISK OF FRACTURES IN PROSTATE CANCER PATIENTS: RESULTS FROM THE POPULATION-BASED PCBASE SWEDEN
    Adolfsson, J.
    Thorstenson, A.
    Bratt, O.
    Hellborg, H.
    Holmberg, L.
    Lambe, M.
    Bill-Axelson, A.
    Stattin, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 337 - 338
  • [5] Psychiatric treatment in men with prostate cancer - Results from a Nation-wide, population-based cohort study from PCBaSe Sweden
    Bill-Axelson, Anna
    Garmo, Hans
    Nyberg, Ullakarin
    Lambe, Mats
    Bratt, Ola
    Stattin, Par
    Adolfsson, Jan
    Steineck, Gunnar
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (14) : 2195 - 2201
  • [6] Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden
    Thorstenson, Andreas
    Bratt, Ola
    Akre, Olof
    Hellborg, Henrik
    Holmberg, Lars
    Lambe, Mats
    Bill-Axelson, Anna
    Stattin, Paer
    Adolfsson, Jan
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (11) : 1672 - 1681
  • [7] Suicide Risk in Men with Prostate-Specific Antigen-Detected Early Prostate Cancer: A Nationwide Population-Based Cohort Study from PCBaSe Sweden
    Bill-Axelson, Anna
    Garmo, Hans
    Lambe, Mats
    Bratt, Ola
    Adolfsson, Jan
    Nyberg, Ullakarin
    Steineck, Gunnar
    Stattin, Par
    EUROPEAN UROLOGY, 2010, 57 (03) : 390 - 395
  • [8] SOCIOECONOMIC STATUS, DIAGNOSTIC INTENSITY, TREATMENT AND MORTALITY IN MEN WITH HIGH RISK PROSTATE CANCER: A POPULATION-BASED STUDY IN PCBASE SWEDEN
    Berglund, A.
    Garmo, H.
    Robinsson, D.
    Tishelman, C.
    Holmberg, L.
    Bratt, O.
    Stattin, J. P.
    Lambe, M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S161 - S161
  • [9] Mortality Among Men with Locally Advanced Prostate Cancer Managed with Noncurative Intent: A Nationwide Study in PCBaSe Sweden
    Akre, Olof
    Garmo, Hans
    Adolfsson, Jan
    Lambe, Mats
    Bratt, Ola
    Stattin, Par
    EUROPEAN UROLOGY, 2011, 60 (03) : 554 - 563
  • [10] PCBaSe Sweden: A register-based resource for prostate cancer research
    Hagel, Eva
    Garmo, Hans
    Bill-Axelson, Anna
    Bratt, Ola
    Johansson, Jan-Erik
    Adolfsson, Jan
    Lambe, Mats
    Stattin, Par
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2009, 43 (05): : 342 - 349
12345